Annals of Oncology

in this issue

In this issue
Ann Oncol 2008 19: 1211; doi:10.1093/annonc/mdn415 [Extract] [Full Text] [PDF] [Request Permissions]  

editorials

L. Del Mastro

The difficult decision-making process for using or not using adjuvant chemotherapy in premenopausal endocrine-responsive breast cancer patients
Annals of Oncology Advance Access published on April 11, 2008
Ann Oncol 2008 19: 1213-1215; doi:10.1093/annonc/mdn157 [Extract] [Full Text] [PDF] [Request Permissions]  

C. Simonelli, M. A. Annunziata, E. Chimienti, M. Berretta, and U. Tirelli

Cancer survivorship: a challenge for the European oncologists
Annals of Oncology Advance Access published on June 4, 2008
Ann Oncol 2008 19: 1216-1217; doi:10.1093/annonc/mdn384 [Extract] [Full Text] [PDF] [Request Permissions]  

reviews

Get checked abstract G. Giaccone and P. A. Zucali

Src as a potential therapeutic target in non-small-cell lung cancer
Annals of Oncology Advance Access published on April 3, 2008
Ann Oncol 2008 19: 1219-1223; doi:10.1093/annonc/mdn048 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Get checked abstract Y. J. Chua and J. R. Zalcberg

Pancreatic cancer—is the wall crumbling?
Annals of Oncology Advance Access published on April 1, 2008
Ann Oncol 2008 19: 1224-1230; doi:10.1093/annonc/mdn063 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

original articles

breast cancer

Get checked abstract M. M. Regan, O. Pagani, B. Walley, R. Torrisi, E. A. Perez, P. Francis, G. F. Fleming, K. N. Price, B. Thürlimann, R. Maibach, M. Castiglione-Gertsch, A. S. Coates, A. Goldhirsch, R. D. Gelber, and for the SOFT/TEXT/PERCHE Steering Committee and the International Breast Cancer Study Group

Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?
Annals of Oncology Advance Access published on March 5, 2008
Ann Oncol 2008 19: 1231-1241; doi:10.1093/annonc/mdn037 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract S. Dawood, K. Broglio, F. J. Esteva, N. K. Ibrahim, S.-W. Kau, R. Islam, K. D. Aldape, T.-K. Yu, G. N. Hortobagyi, and A. M. Gonzalez-Angulo

Defining prognosis for women with breast cancer and CNS metastases by HER2 status
Annals of Oncology Advance Access published on March 11, 2008
Ann Oncol 2008 19: 1242-1248; doi:10.1093/annonc/mdn036 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract S. Mahner, S. Schirrmacher, W. Brenner, L. Jenicke, C. R. Habermann, N. Avril, and J. Dose-Schwarz

Comparison between positron emission tomography using 2-[fluorine-18]fluoro-2-deoxy-D-glucose, conventional imaging and computed tomography for staging of breast cancer
Annals of Oncology Advance Access published on March 19, 2008
Ann Oncol 2008 19: 1249-1254; doi:10.1093/annonc/mdn057 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract V. Diéras, S. Limentani, G. Romieu, M. Tubiana-Hulin, A. Lortholary, P. Kaufman, V. Girre, M. Besenval, and V. Valero

Phase II multicenter study of larotaxel (XRP9881), a novel taxoid, in patients with metastatic breast cancer who previously received taxane-based therapy
Annals of Oncology Advance Access published on April 1, 2008
Ann Oncol 2008 19: 1255-1260; doi:10.1093/annonc/mdn060 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract F.-C. Bidard, M.-C. Matthieu, P. Chollet, I. Raoefils, C. Abrial, J. Dômont, M. Spielmann, S. Delaloge, F. André, and F. Penault-Llorca

p53 status and efficacy of primary anthracyclines/alkylating agent-based regimen according to breast cancer molecular classes
Annals of Oncology Advance Access published on March 5, 2008
Ann Oncol 2008 19: 1261-1265; doi:10.1093/annonc/mdn039 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract R. von Moos, C. B. Caspar, B. Thürlimann, R. Angst, R. Inauen, R. Greil, B. Bergstrom, K. Schmieding, and M. Pecherstorfer

Renal safety profiles of ibandronate 6 mg infused over 15 and 60 min: a randomized, open-label study
Annals of Oncology Advance Access published on March 11, 2008
Ann Oncol 2008 19: 1266-1270; doi:10.1093/annonc/mdn038 [Abstract] [Full Text] [PDF] [Request Permissions]  

gynecologic tumors

Get checked abstract A. Psyrri, P. Kountourakis, A. Scorilas, S. Markakis, R. Camp, D. Kowalski, E. P. Diamandis, and M. A. Dimopoulos

Human tissue kallikrein 7, a novel biomarker for advanced ovarian carcinoma using a novel in situ quantitative method of protein expression
Annals of Oncology Advance Access published on March 5, 2008
Ann Oncol 2008 19: 1271-1277; doi:10.1093/annonc/mdn035 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract G. Mangili, S. Montoli, P. De Marzi, I. Sassi, G. Aletti, G. Aletti, and G. Taccagni

The role of DNA ploidy in postoperative management of stage I endometrial cancer
Annals of Oncology Advance Access published on March 19, 2008
Ann Oncol 2008 19: 1278-1283; doi:10.1093/annonc/mdn041 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract S. Suzuki, H. Kajiyama, K. Shibata, K. Ino, A. Nawa, K. Sakakibara, K. Matsuzawa, A. Takeda, Y. Kinoshita, M. Kawai, T. Nagasaka, and F. Kikkawa

Is there any association between retroperitoneal lymphadenectomy and survival benefit in ovarian clear cell carcinoma patients?
Annals of Oncology Advance Access published on March 19, 2008
Ann Oncol 2008 19: 1284-1287; doi:10.1093/annonc/mdn059 [Abstract] [Full Text] [PDF] [Request Permissions]  

gastrointestinal tumors

Get checked abstract M. Borner, D. Koeberle, R. Von Moos, P. Saletti, D. Rauch, V. Hess, A. Trojan, D. Helbling, B. Pestalozzi, C. Caspar, T. Ruhstaller, A. Roth, A. Kappeler, D. Dietrich, D. Lanz, W. Mingrone, and for the Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland

Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKK
Annals of Oncology Advance Access published on March 17, 2008
Ann Oncol 2008 19: 1288-1292; doi:10.1093/annonc/mdn058 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract C. Braconi, R. Bracci, I. Bearzi, F. Bianchi, S. Sabato, A. Mandolesi, L. Belvederesi, S. Cascinu, N. Valeri, and R. Cellerino

Insulin-like growth factor (IGF) 1 and 2 help to predict disease outcome in GIST patients
Annals of Oncology Advance Access published on March 27, 2008
Ann Oncol 2008 19: 1293-1298; doi:10.1093/annonc/mdn040 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract K. N. Prasad, A. Saxena, U. C. Ghoshal, M. R. Bhagat, and N. Krishnani

Analysis of Pro12Ala PPAR gamma polymorphism and Helicobacter pylori infection in gastric adenocarcinoma and peptic ulcer disease
Annals of Oncology Advance Access published on March 27, 2008
Ann Oncol 2008 19: 1299-1303; doi:10.1093/annonc/mdn055 [Abstract] [Full Text] [PDF] [Request Permissions]  

urogenital tumors

Get checked abstract C. Theodore, I. Skoneczna, I. Bodrogi, M. Leahy, J. M. Kerst, L. Collette, K. Ven, S. Marréaud, R. D. T. Oliver, and for the EORTC Genito-Urinary Tract Cancer Group

A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992)
Annals of Oncology Advance Access published on April 15, 2008
Ann Oncol 2008 19: 1304-1307; doi:10.1093/annonc/mdn149 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract R. Thuret, C. Massard, M. Gross-Goupil, B. Escudier, M. Di Palma, A. Bossi, R. de Crevoisier, A. Chauchereau, and K. Fizazi

The postchemotherapy PSA surge syndrome
Annals of Oncology Advance Access published on March 19, 2008
Ann Oncol 2008 19: 1308-1311; doi:10.1093/annonc/mdn062 [Abstract] [Full Text] [PDF] [Request Permissions]  

hematologic malignancies

Get checked abstract B. Sirohi, D. Cunningham, R. Powles, F. Murphy, T. Arkenau, A. Norman, J. Oates, A. Wotherspoon, and A. Horwich

Long-term outcome of autologous stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma
Annals of Oncology Advance Access published on March 19, 2008
Ann Oncol 2008 19: 1312-1319; doi:10.1093/annonc/mdn052 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract R. Capdeville, T. Krahnke, A. Hatfield, J. M. Ford, I. Van Hoomissen, and I. Gathmann

Report of an international expanded access program of imatinib in adults with Philadelphia chromosome positive leukemias
Annals of Oncology Advance Access published on March 15, 2008
Ann Oncol 2008 19: 1320-1326; doi:10.1093/annonc/mdn050 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract P. Martin, A. Chadburn, P. Christos, R. Furman, J. Ruan, M. A. Joyce, E. Fusco, P. Glynn, R. Elstrom, R. Niesvizky, E. J. Feldman, T. B. Shore, M. W. Schuster, S. Ely, D. M. Knowles, S. Chen-Kiang, M. Coleman, and J. P. Leonard

Intensive treatment strategies may not provide superior outcomes in mantle cell lymphoma: overall survival exceeding 7 years with standard therapies
Annals of Oncology Advance Access published on March 17, 2008
Ann Oncol 2008 19: 1327-1330; doi:10.1093/annonc/mdn045 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract L. Arcaini, F. Montanari, E. P. Alessandrino, A. Tucci, E. Brusamolino, L. Gargantini, R. Cairoli, P. Bernasconi, F. Passamonti, M. Bonfichi, V. Zoli, C. Bottelli, S. Calatroni, D. Troletti, M. Merli, C. Pascutto, I. Majolino, G. Rossi, E. Morra, and M. Lazzarino

Immunochemotherapy with in vivo purging and autotransplant induces long clinical and molecular remission in advanced relapsed and refractory follicular lymphoma
Annals of Oncology Advance Access published on March 15, 2008
Ann Oncol 2008 19: 1331-1335; doi:10.1093/annonc/mdn044 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract M. Troch, S. Woehrer, B. Streubel, M. Weissel, M. Hoffmann, L. Müllauer, A. Chott, and M. Raderer

Chronic autoimmune thyroiditis (Hashimoto's thyroiditis) in patients with MALT lymphoma
Annals of Oncology Advance Access published on March 11, 2008
Ann Oncol 2008 19: 1336-1339; doi:10.1093/annonc/mdn049 [Abstract] [Full Text] [PDF] [Request Permissions]  

miscellaneous tumors

Get checked abstract E. R. Brown, K. A. Charles, S. A. Hoare, R. L. Rye, D. I. Jodrell, R. E. Aird, R. Vora, U. Prabhakar, M. Nakada, R. E. Corringham, M. DeWitte, C. Sturgeon, D. Propper, F. R. Balkwill, and J. F. Smyth

A clinical study assessing the tolerability and biological effects of infliximab, a TNF- inhibitor, in patients with advanced cancer
Annals of Oncology Advance Access published on March 5, 2008
Ann Oncol 2008 19: 1340-1346; doi:10.1093/annonc/mdn054 [Abstract] [Full Text] [PDF] [Supplementary Data] [Request Permissions]  

clinical trials

Get checked abstract F. Trotta, G. Apolone, S. Garattini, and G. Tafuri

Stopping a trial early in oncology: for patients or for industry?
Annals of Oncology Advance Access published on February 27, 2008
Ann Oncol 2008 19: 1347-1353; doi:10.1093/annonc/mdn042 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

letters to the editor

G. Mantovani

Circulating interleukin-6 as a tumor marker for hepatocellular carcinoma
Annals of Oncology Advance Access published on June 2, 2008
Ann Oncol 2008 19: 1355; doi:10.1093/annonc/mdn290 [Extract] [Full Text] [PDF] [Request Permissions]  

S. Matsuda, S. Yokozaki, H. Yoshida, Y. Kitagishi, N. Shirafuji, and N. Okumura

Insulin receptor substrate protein 53 (IRSp53) as a binding partner of antimetastasis molecule NESH, a member of Abelson interactor protein family
Annals of Oncology Advance Access published on May 13, 2008
Ann Oncol 2008 19: 1356-1357; doi:10.1093/annonc/mdn293 [Extract] [Full Text] [PDF] [Request Permissions]  

T. Van den Wyngaert, M. T. Huizing, and J. B. Vermorken

Disambiguating the bisphosphonates
Annals of Oncology Advance Access published on June 2, 2008
Ann Oncol 2008 19: 1357-1359; doi:10.1093/annonc/mdn356 [Extract] [Full Text] [PDF] [Request Permissions]  

D. Errante, A. Bianco, S. M. L. Aversa, and L. Salvagno On behalf of the Non-Hodgkin's Lymphoma Cooperative Study Group (NHLCSG)

Comment on: ‘Non-Hodgkin's lymphoma in very elderly patients over 80 years. A descriptive analysis of clinical presentation and outcome’
Annals of Oncology Advance Access published on May 21, 2008
Ann Oncol 2008 19: 1359-1360; doi:10.1093/annonc/mdn355 [Extract] [Full Text] [PDF] [Request Permissions]  

A. Avilés

Breast lymphoma
Ann Oncol 2008 19: 1360; doi:10.1093/annonc/mdn379 [Extract] [Full Text] [PDF] [Request Permissions]  

A. Ardavanis, G. Orphanos, S. Skafida, S. Basioukas, and G. Rigatos

Coincidential successful treatment of Jessner–Kanof disease with chemotherapy
Annals of Oncology Advance Access published on June 4, 2008
Ann Oncol 2008 19: 1360-1361; doi:10.1093/annonc/mdn387 [Extract] [Full Text] [PDF] [Request Permissions]  

C. Christodoulou, S. Murray, J. Dahabreh, K. Petraki, A. Nikolakopoulou, A. Mavri, and D. Skarlos

Response of malignant thymoma to erlotinib
Annals of Oncology Advance Access published on June 4, 2008
Ann Oncol 2008 19: 1361-1362; doi:10.1093/annonc/mdn388 [Extract] [Full Text] [PDF] [Request Permissions]  

corrigendum

Volume 18, Supplement 3, A global comparison regarding patient access to cancer drugs
Ann Oncol 2008 19: 1363; doi:10.1093/annonc/mdn382 [Extract] [Full Text] [PDF] [Request Permissions]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.